請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/67546
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 金傳春(Chwan-Chuen King) | |
dc.contributor.author | Chi-Hang Chin | en |
dc.contributor.author | 錢智恆 | zh_TW |
dc.date.accessioned | 2021-06-17T01:37:01Z | - |
dc.date.available | 2022-08-28 | |
dc.date.copyright | 2017-08-28 | |
dc.date.issued | 2017 | |
dc.date.submitted | 2017-07-31 | |
dc.identifier.citation | Akey, D. L., et al. (2014). 'Flavivirus NS1 structures reveal surfaces for associations with membranes and the immune system.' Science 343(6173): 881-885.
Anderson, J. R. and R. Rico-Hesse (2006). 'Aedes aegypti vectorial capacity is determined by the infecting genotype of dengue virus.' The American journal of tropical medicine and hygiene 75(5): 886-892. Avirutnan, P., et al. (2010). 'Antagonism of the complement component C4 by flavivirus nonstructural protein NS1.' Journal of Experimental Medicine: jem. 20092545. Avirutnan, P., et al. (1998). 'Dengue virus infection of human endothelial cells leads to chemokine production, complement activation, and apoptosis.' The Journal of Immunology 161(11): 6338-6346. Avirutnan, P., et al. (2006). 'Vascular leakage in severe dengue virus infections: a potential role for the nonstructural viral protein NS1 and complement.' Journal of Infectious Diseases 193(8): 1078-1088. Avirutnan, P., et al. (2007). 'Secreted NS1 of dengue virus attaches to the surface of cells via interactions with heparan sulfate and chondroitin sulfate E.' PLoS Pathog 3(11): e183. Beatty, P. R., et al. (2015). 'Dengue virus NS1 triggers endothelial permeability and vascular leak that is prevented by NS1 vaccination.' Science Translational Medicine 7(304): 304ra141-304ra141. Bhatt, S., et al. (2013). 'The global distribution and burden of dengue.' Nature 496(7446): 504-507. Binder, H. J. (1990). 'Pathophysiology of acute diarrhea.' The American journal of medicine 88(6): S2-S4. Brady, O. J., et al. (2012). 'Refining the global spatial limits of dengue virus transmission by evidence-based consensus.' PLoS Negl Trop Dis 6(8): e1760. Carvalho, D. M., et al. (2014). 'Elevated dengue virus nonstructural protein 1 serum levels and altered toll-like receptor 4 expression, nitric oxide, and tumor necrosis factor alpha production in dengue hemorrhagic fever patients.' Journal of tropical medicine 2014. Chang, G.-J. (1997). 'Molecular biology of dengue viruses.' Dengue and dengue hemorrhagic fever. Chang, H.-H., et al. (2002). 'Facilitation of cell adhesion by immobilized dengue viral nonstructural protein 1 (NS1): arginine-glycine-aspartic acid structural mimicry within the dengue viral NS1 antigen.' Journal of Infectious Diseases 186(6): 743-751. Chang, R.-Y., et al. (2013). 'Japanese encephalitis virus non-coding RNA inhibits activation of interferon by blocking nuclear translocation of interferon regulatory factor 3.' Veterinary microbiology 166(1): 11-21. Chang, S.-F., et al. (2012). 'Characteristics of dengue epidemics in Taiwan.' Journal of the Formosan Medical Association 111(6): 297-299. Chao, D.-Y., et al. (2004). '1998 dengue hemorrhagic fever epidemic in Taiwan.' Emerging infectious diseases 10(3): 552. Chen, H.-L., et al. (2008). 'Evolution of dengue virus type 2 during two consecutive outbreaks with an increase in severity in southern Taiwan in 2001–2002.' The American journal of tropical medicine and hygiene 79(4): 495-505. Chen, H.-R., et al. (2016). 'Dengue Virus Nonstructural Protein 1 Induces Vascular Leakage through Macrophage Migration Inhibitory Factor and Autophagy.' PLoS Negl Trop Dis 10(7): e0004828. Chien, L.-J., et al. (2006). 'Development of real-time reverse transcriptase PCR assays to detect and serotype dengue viruses.' Journal of clinical microbiology 44(4): 1295-1304. Falconar, A. (1997). 'The dengue virus nonstructural-1 protein (NS1) generatesantibodies to common epitopes on human blood clotting, integrin/adhesin proteins and binds to humanendothelial cells: potential implications in haemorrhagic fever pathogenesis.' Archives of virology 142(5): 897-916. Falconar, A. K. and P. R. Young (1990). 'Immunoaffinity purification of native dimer forms of the flavivirus non-structural glycoprotein, NS1.' Journal of virological methods 30(3): 323-332. Gubler, D., et al. (1981). 'Epidemic dengue 3 in central Java, associated with low viremia in man.' The American journal of tropical medicine and hygiene 30(5): 1094-1099. Gutsche, I., et al. (2011). 'Secreted dengue virus nonstructural protein NS1 is an atypical barrel-shaped high-density lipoprotein.' Proceedings of the National Academy of Sciences 108(19): 8003-8008. Guzmán, M. G., et al. (2000). 'Do escape mutants explain rapid increases in dengue casefatality rates within epidemics?' The Lancet 355(9218): 1902-1903. Hall, T. A. (1999). BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic acids symposium series, [London]: Information Retrieval Ltd., c1979-c2000. Halstead, S., et al. (1967). 'Hemorrhagic fever in Thailand; recent knowledge regarding etiology.' Japanese journal of medical science & biology 20: 96-103. Halstead, S. B. (2003). 'Neutralization and antibody-dependent enhancement of dengue viruses.' Advances in virus research 60: 421-467. Hsieh, W., et al. (1982). 'Outbreak of dengue fever in 1981 in Liouchyou Shiang, Pingtung County.' Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association 81(11): 1388. Huang, C. Y.-H., et al. (2010). 'The dengue virus type 2 envelope protein fusion peptide is essential for membrane fusion.' Virology 396(2): 305-315. Hung, S.-L., et al. (1999). 'Analysis of the steps involved in dengue virus entry into host cells.' Virology 257(1): 156-167. Kan, C.-C., et al. (2008). 'Two clustering diffusion patterns identified from the 2001–2003 dengue epidemic, Kaohsiung, Taiwan.' The American journal of tropical medicine and hygiene 79(3): 344-352. Kao, J.-H., et al. (2016). 'The Critical Role of Early Dengue Surveillance and Limitations of Clinical Reporting–Implications for Non-Endemic Countries.' PLoS One 11(8): e0160230. King, C. A., et al. (2002). 'Dengue virus selectively induces human mast cell chemokine production.' Journal of virology 76(16): 8408-8419. Kroeger, A. and M. B. Nathan (2007). 'Dengue: setting the global research agenda.' The Lancet 368(9554): 2193-2195. Kuan, M.-M., et al. (2010). 'Epidemiological trends and the effect of airport fever screening on prevention of domestic dengue fever outbreaks in Taiwan, 1998–2007.' International Journal of Infectious Diseases 14(8): e693-e697. Kurane, I., et al. (2011). 'T-cell responses to dengue virus in humans.' Tropical medicine and health 39(4SUPPLEMENT): S45-S51. Kurosu, T., et al. (2007). 'Secreted complement regulatory protein clusterin interacts with dengue virus nonstructural protein 1.' Biochemical and biophysical research communications 362(4): 1051-1056. Lee, M.-S., et al. (2006). 'Clinical characteristics of dengue and dengue hemorrhagic fever in a medical center of southern Taiwan during the 2002 epidemic.' Journal of microbiology, immunology, and infection= Wei mian yu gan ran za zhi 39(2): 121-129. Libraty, D. H., et al. (2002). 'High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever.' Journal of Infectious Diseases 186(8): 1165-1168. Lin, C.-F., et al. (2005). 'Expression of cytokine, chemokine, and adhesion molecules during endothelial cell activation induced by antibodies against dengue virus nonstructural protein 1.' The Journal of Immunology 174(1): 395-403. Lin, C.-F., et al. (2002). 'Endothelial cell apoptosis induced by antibodies against dengue virus nonstructural protein 1 via production of nitric oxide.' The Journal of Immunology 169(2): 657-664. Lin, C.-F., et al. (2006). 'Autoimmune pathogenesis in dengue virus infection.' Viral immunology 19(2): 127-132. Lindenbach, B. D. and C. M. Rice (1999). 'Genetic interaction of flavivirus nonstructural proteins NS1 and NS4A as a determinant of replicase function.' Journal of virology 73(6): 4611-4621. Littaua, R., et al. (1990). 'Human IgG Fc receptor II mediates antibody-dependent enhancement of dengue virus infection.' The Journal of Immunology 144(8): 3183-3186. Liu, J., et al. (2016). 'Flavivirus NS1 protein in infected host sera enhances viral acquisition by mosquitoes.' Nature Microbiology 1: 16087. Liu, Y., et al. (2017). 'Evolutionary enhancement of Zika virus infectivity in Aedes aegypti mosquitoes.' Nature 545(7655): 482-486. Malavige, G. N., et al. (2012). 'Cellular and cytokine correlates of severe dengue infection.' PLoS One 7(11): e50387. Martina, B. E., et al. (2009). 'Dengue virus pathogenesis: an integrated view.' Clinical microbiology reviews 22(4): 564-581. McBride, W. J. and H. Bielefeldt-Ohmann (2000). 'Dengue viral infections; pathogenesisand epidemiology.' Microbes and infection 2(9): 1041-1050. Moon, S. L., et al. (2012). 'A noncoding RNA produced by arthropod-borne flaviviruses inhibits the cellular exoribonuclease XRN1 and alters host mRNA stability.' Rna 18(11): 2029-2040. Muller, D. A. and P. R. Young (2013). 'The flavivirus NS1 protein: molecular and structural biology, immunology, role in pathogenesis and application as a diagnostic biomarker.' Antiviral research 98(2): 192-208. Puerta-Guardo, H., et al. (2016). 'Dengue virus NS1 disrupts the endothelial glycocalyx, leading to hyperpermeability.' PLoS pathogens 12(7): e1005738. Ramsingh, A., et al. (1995). 'Genetic mapping of the determinants of plaque morphology of coxsackievirus B4.' Archives of virology 140(12): 2215-2226. Rice, C. M. (1996). 'Flaviviridae: the viruses and their replication.' Fields virology 3: 931-959. Rico-Hesse, R. (1990). 'Molecular evolution and distribution of dengue viruses type 1 and 2 in nature.' Virology 174(2): 479-493. Rico-Hesse, R., et al. (1997). 'Origins of dengue type 2 viruses associated with increased pathogenicity in the Americas.' Virology 230(2): 244-251. Ritchie, S. A., et al. (2013). 'An explosive epidemic of DENV-3 in Cairns, Australia.' PLoS One 8(7): e68137. Rodenhuis-Zybert, I. A., et al. (2010). 'Dengue virus life cycle: viral and host factors modulating infectivity.' Cellular and molecular life sciences 67(16): 2773-2786. Sam, S.-S., et al. (2015). 'High producing tumor necrosis factor alpha gene alleles in protection against severe manifestations of dengue.' International journal of medical sciences 12(2): 177. Sanger, F., et al. (1992). 'DNA sequencing with chain-terminating inhibitors. 1977.' Biotechnology (Reading, Mass.) 24: 104. Scaturro, P., et al. (2015). 'Dengue virus non-structural protein 1 modulates infectious particle production via interaction with the structural proteins.' PLoS pathogens 11(11): e1005277. SUN, D. S., et al. (2007). 'Antiplatelet autoantibodies elicited by dengue virus non‐structural protein 1 cause thrombocytopenia and mortality in mice.' Journal of Thrombosis and Haemostasis 5(11): 2291-2299. Tee, H., et al. (2009). 'Risk factors associated with development of dengue haemorrhagic fever or dengue shock syndrome in adults in Hospital Tengku Ampuan Afzan Kuantan.' Medical Journal of Malaysia 64(4): 263-267. Thomas, L., et al. (2008). 'Influence of the dengue serotype, previous dengue infection, and plasma viral load on clinical presentation and outcome during a dengue-2 and dengue-4 co-epidemic.' The American journal of tropical medicine and hygiene 78(6): 990-998. Toledo, J., et al. (2016). 'Relevance of non-communicable comorbidities for the development of the severe forms of dengue: a systematic literature review.' PLoS neglected tropical diseases 10(1): e0004284. Tricou, V., et al. (2011). 'Kinetics of viremia and NS1 antigenemia are shaped by immune status and virus serotype in adults with dengue.' PLoS Negl Trop Dis 5(9): e1309. Tsai, H.-P., et al. (2016). 'Validation and application of a commercial quantitative real-time reverse transcriptase-PCR assay in investigation of a large dengue virus outbreak in southern Taiwan.' PLoS neglected tropical diseases 10(10): e0005036. Ubol, S., et al. (2008). 'Clinical isolates of dengue virus with distinctive susceptibility to nitric oxide radical induce differential gene responses in THP-1 cells.' Virology 376(2): 290-296. Vasilakis, N., et al. (2007). 'Potential of ancestral sylvatic dengue-2 viruses to re-emerge.' Virology 358(2): 402-412. Vaughn, D. W., et al. (2000). 'Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity.' Journal of Infectious Diseases 181(1): 2-9. Wang, W.-K., et al. (2003). 'High levels of plasma dengue viral load during defervescence in patients with dengue hemorrhagic fever: implications for pathogenesis.' Virology 305(2): 330-338. Wen, T.-H., et al. (2010). 'Spatial–temporal patterns of dengue in areas at risk of dengue hemorrhagic fever in Kaohsiung, Taiwan, 2002.' International Journal of Infectious Diseases 14(4): e334-e343. Westaway, E. G., et al. (1997). 'Ultrastructure of Kunjin virus-infected cells: colocalization of NS1 and NS3 with double-stranded RNA, and of NS2B with NS3, in virus-induced membrane structures.' Journal of virology 71(9): 6650-6661. Winkler, G., et al. (1988). 'Evidence that the mature form of the flavivirus nonstructural protein NS1 is a dimer.' Virology 162(1): 187-196. Wu, Y.-C. (1986). 'Epidemic dengue 2 on Liouchyou Shiang, Pingtung County in 1981.' Zhonghua Minguo wei sheng wu ji mian yi xue za zhi= Chinese journal of microbiology and immunology 19(3): 203-211. Youn, S., et al. (2013). 'Non-structural protein-1 is required for West Nile virus replication complex formation and viral RNA synthesis.' Virology journal 10(1): 339. Youn, S., et al. (2012). 'Evidence for a genetic and physical interaction between nonstructural proteins NS1 and NS4B that modulates replication of West Nile virus.' Journal of virology 86(13): 7360-7371. Young, P. R., et al. (2000). 'An antigen capture enzyme-linked immunosorbent assay reveals high levels of the dengue virus protein NS1 in the sera of infected patients.' Journal of clinical microbiology 38(3): 1053-1057. 舒佩芸 (2016)第一節 台灣登革熱分子流行病學, 第一章登革熱流行病學, In BOOK on 「登革熱的台灣經驗 - 從流行病學及臨床到基礎科學的新視野」, 科技部台灣重要新興感染症研究計畫成果報告,科技部出版。翊立印刷有限公司, Taiwan. 劉英姿 方啟泰 顏哲傑 (2015) 2003至2013年台灣地區登革熱併發登革出血熱危險因子分析 台灣衛誌 2015;34(4):437-446) | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/67546 | - |
dc.description.abstract | 台灣南部的高雄和台南自1987年幾乎每年有登革熱流行,在2001-2002年高雄和2015年台南均發生了第二型登革病毒所引起的登革熱大流行,分別造成5,041和22,770例登革熱確定病例;有趣的是在此兩波流行中病人的臨床症狀卻有差異。本研究目的有三︰(一)比較此兩波流行的臨床表徵與流行病學特徵,(二)比較造成此兩波登革熱流行的病毒株在基因型和表現型的差異,及(三)串聯臨床﹑流行病學與病毒學的結果,以綜觀流行全貌。
比對此兩波流行自病人血清中所分離得的第二型登革病毒株的全長核苷酸序列[高雄(Kaohsiung, KH) 40株、台南(Tainan, TN) 7株],而高雄的病毒株的核苷酸彼此間之相同度高於99.872%,台南病毒株彼此間的相同性高於99.953%,因此從中挑選出分別代表兩波流行來自登革病患的病毒株,並利用Vero細胞(V)進行兩(V2)至三次(V3)病毒斑純化,再利用蚊子C6/36細胞進行病毒複製兩次(C2),後續以純化後的各兩病毒代表株[2002-KH-A3L(V2C2)及2015-TN-6B1 (V3C2)]進行實驗。做法上,先分析臨床病人的流行病學與臨床病症數據,接着比對此兩病毒代表株在Vero細胞及蚊子C6/36細胞上的胞外及胞內的生長動力學與細胞毒性、在嬰兒倉鼠腎細胞(baby hamster kidney, BHK)的斑塊形態、細胞結合力、細胞穿透力、複製力、胞內與胞外非結構性蛋白1表現量(non-structural protein 1, NS1)及人類腸道細胞(Caco-2)的感染性等實驗,藉此比較造成這兩波流行的第二型登革病毒株在表徵上的差異及其與流行病學差異的關聯性;並以單變項 (卡方檢定、獨立學生t檢定)等統計法檢驗分析。 在流行病學特徵,發現2015年台南登革熱病例比2002年高雄女男比較低(1.01 vs 1.17, p<0.05)、平均年齡較低(45.66 ± 21.15 vs 47.52 ± 17.78歲, p<0.05)、腸胃道症狀率較高[12.23% (2785/22770) vs 4.30% (217/5041), p<0.0001]及病例的住院率較低[11.10% (2527/22770) vs 39.63% (1998/5041), p<0.001];雖然兩波流行病例的致死率並無差異(0.56% vs 0.54%, p=0.29),但2015年台南的登革住院死亡率顯著較高[(5.03% (127/2527) vs 1.25% (25/1998), p<0.05)。 演化分析引發此兩波流行的兩病毒代表株(2002-KH-A3L及2015-TN-6B1),發現其均屬於都會基因型(Cosmopolitan genotype)的兩不同分群,但其在核苷酸的相同度為97.506%,胺基酸的相同度更高達99.322%。在病毒表現型上,生長動力學實驗顯示2015年台南代表株(2015-TN-6B1)在感染Vero細胞前期(感染後24與36小時)和感染C6/36細胞後24、72與120小時比2002-KH-A3L病毒株有較高的細胞外病毒量,且感染Vero細胞後24小時造成較高的細胞死亡數。兩株病毒在感染BHK細胞所產生的病毒斑塊形態和細胞結合能力均無差異,可是2015-TN-6B1病毒株在BHK細胞作用0、15與30分鐘後的穿透力(penetration)及的複製力均表現較佳。值得注意的的是2015-TN-6B1病毒株在感染Vero細胞後24﹑48及96小時所產生的胞內NS1也較多;而2002-KH-A3L病毒株在此同感染力而感染Vero細胞後48﹑72及96小時所產生的胞外NS1和NS1總量卻較高。更重要的是2015-TN-6B1病毒株感染人腸道Caco-2細胞後24、48及72時的胞外病毒量較高以及其在此細胞感染後96及144小時所呈現的病毒免疫螢光訊號也較高,再度證實2015台南病毒株在人腸道細胞的感染或複製力較高。 本研究的主要限制有四:(一)僅選出分別代表2001-2002年高雄和2015年台南兩波流行來自登革病患各一株的第二型登革病毒株;(二)除了病毒因素外,病人的登革感染史﹑群體免疫﹑共病、病人基因、病媒與環境﹑氣候及人為介入等因子均會導致此兩波流行的差異;(三)未測病人的免疫狀況,致無法更佳串連登革病毒與宿主的關係;及(四)尚未純化得不同的足量NS1蛋白以釐清其差異的機轉。 本研究發現引起2015年台南登革流行的第二型登革病毒株在生長動力學表現比導致2002年高雄登革流行的同血清型登革病毒株為佳,2015台南株在病毒的穿透力、複製力及胞內NS1量均表現較佳,可能因而造成2015年台南的流行幅度比2002年高雄為大;再加上2015台南株對於人腸道細胞的感染或複製力也較高,此可能解釋為何2015年台南登革病人有較高的腸胃症狀。未來應收集具時空流行病學特徵的的病人檢體,利用次世代定序分析在流行過程中病毒亞群的動態改變;再者,利用質譜議分析病毒NS1蛋白的轉譯後修飾等表徵,最後整合個人與族群層面的臨床、流行病學、病毒學與免疫學結果,定能明瞭為何某些流行較為嚴重的原因與機轉。 | zh_TW |
dc.description.abstract | Kaohsiung and Tainan (located in southern Taiwan) have experienced annual epidemics of dengue since 1987. There were two large-scale outbreaks caused by serotype-2 dengue virus (DENV-2), in Kaohsiung (KH) in 2001-2002 and in Tainan (TN) in 2015, resulting in 5041 and 22,770 total cases, respectively. However,the clinical manifestations of these two epidemics were different. This study had 3 specific aims: (1) to compare epidemiological and clinical manifestations of these two epidemics, (2) to evaluate virological characteristics of the two DENV-2 viruses genotypically and phenotypically, and (3) to integrate clinical, epidemiological and virological characteristics for better understanding the differences in overall picture of these two epidemics.
Full-length viral nucleotides sequences, obtained by using Sanger sequencing, of the isolated viruses from 2001-02 KH and 2015 TN patients’ serum samples were analyzed in order to acquire the representative virus strains of the corresponding epidemics. The full-length nucleotides sequences of 47 virus strains (40 of KH, 7 of TN) within the same epidemic shared extremely high identities (>99.872% for Kaohsiung strains and >99.953% for Tainan strains). Representative virus strains of these two epidemics were plaque-purified two (V2) to three(V3) times from Vero cells (V) and then amplified in Aedes albopictus C6/36 cells (C). Epidemiological data and clinical manifestation of laboratory-confirmed dengue patients of these two epidemics were analyzed. Growth kinetics and cell toxicity of these two representative DENV-2 strains [2002-KH-A3L (V2C2) and 2015-TN-6B1 (V3C2)] were evaluated by collecting infected supernatant and Vero cells at different time points [0, 24, 36, 48, 72, 96 hour post-infection, (h.p.i.)]. Focus-forming assay (FFA) and real-time polymerase chain reaction (qPCR) were used to quantify viral RNA copies in both infected supernatant and cells. Trypan blue was used to quantify survived cells to assess cell toxicity. Viral plaque morphologies, and other phenotypic abilities in cell binding, penetration, replication and expression levels of intracellular and extracellular non-structural protein 1 (NS1), using in-house ELISA to quantify, in baby hamster kidney (BHK) or Vero cells were also examined. Virus infectivity in human colon epithelial cells (Caco-2) were evaluated through growth kinetics and immunofluorescent assay (IFA). Univariate analyses (Chi-square and unpaired t-test) were used to compare the differences between these two epidemics. Comparing to those results of the 2001-2002 Kaohsiung DENV-2 epidemic, epidemiological analyses showed that the 2015 Tainan epidemic had lower female to male ratio (1.01 vs 1.17, p<0.05), lower mean age (45.66 ± 21.15 vs 47.52 ± 17.78 years old, p<0.05), higher frequencies of gastrointestinal symptoms [12.23% (2785/22770) vs 4.30% (217/5041), p<0.0001], lower hospitalization rate [11.10% (2527/22770) vs 39.63% (1998/5041), p<0.001]. Although the case-fatality rate had no difference (0.56% vs 0.54%, p=0.29), the hospitalization fatality rate of the 2015 Tainan epidemic was significantly higher [(5.03% (127/2527) vs 1.25% (25/1998), p<0.05). Evolutionary analyses found that these two DENV-2 strains (2002-KH-A3L and 2015-TN-6B1) all belong to the different clades of the Cosmopolitan genotype. However, they had high viral sequence identity percentages in amino acids (99.322%) and nucleotides (97.506%). Growth kinetics of these two purified viruses revealed that the 2015 Tainan DENV-2 (2015-TN-6B1) strain replicated more efficiently (24 and 36 h.p.i.), and caused more cell death at 24 h.p.i. than those of the 2002 Kaouhsiung DENV-2 (2002-KH-A3L) strain. There was no significant difference in the plaque morphologies or cell binding abilities in BHK cells. However, the penetration ability at 0, 15, 30 minutes post-incubation and replication ability of the 2015-TN-6B1 strain in BHK cells were superior to those from the DENV-2 2002-KH-A3L strain. The intracellular levels of NS1 in these cells infected with the 2015-TN-6B1 strain (MOI=1) at 24, 48, 96 h.p.i were higher. By contrast, those infected with the 2002-KH-A3L strain at 48, 72, 96 h.p.i. showed higher extracellular and total levels of NS1. Most importantly, the human intestine Caco-2 cells infected with the 2015-TN-6B1 strain at 24, 48 and 72 h.p.i demonstrated higher extracellular viral loads shown by FFA than those of the Caco-2 infection with the 2002-KH-A3L. In addition, these Caco-2 cells infected with the 2015-TN-6B1 at 96 and 144 h.p.i. also revealed higher intensities of fluorescent signal in IFA staining of viral antigen either E or NS1. These results showed that the 2015-TN-6B1 strain had higher infectivity or replication efficiency in human intestinal cells than those of the 2002-KH-A3L strain. There are four major limitations of this study. First, we only chose one DENV-2 viral strain from the dengue patient to represent each of the corresponding epidemics. Second, other factors besides viral attribute, such as herd immunity, comorbidity, past history of DENV infection with different serotypes, vector factors, climate, environmental factors, intervention strategies and human behavior may also contribute the differences in these DENV-2 caused two major epidemics. Third, the individual immunity was not measured for better conclusion on the interactions between DENV-2 and human host. Fourth, we failed to purify NS1 of these two representative strains up to suffiecient amount to examine the difference in the mechanism of NS1 in viral pathogenesis. In conclusion, the 2015 TN DENV-2 strain showed better performance in growth kinetics with better penetration, replication abilities and higher levels of intracellular NS1 than those of the 2002 KH strain. This might explain why the 2015 Tainan epidemic was more severe. Moreover, the 2015 TN strain showed better infectivity and higher replication efficiency in human intestinal Caco-2 cells which is well-correlated with the higher percentages of gastrointestinal symptoms in the 2015 epidemic. Future effort needs to collect specimens from different time points of the various epidemic waves with tempo-spatial epidemiological characteristics for analyzing dynamics of DENV subpopulations through epidemic process, using next generation sequencing. In addition, the combination of further viral phenotypic studies can be done to examine the post-translation modification of NS1, using mass spectrometry and proteomics analyses. Based on this study, the integrated results from clinical, epidemiological to virolgical and immunological results at both individual and population levels can give us the best clues to fully understand the reasons why certain epidemic is more severe than others. | en |
dc.description.provenance | Made available in DSpace on 2021-06-17T01:37:01Z (GMT). No. of bitstreams: 1 ntu-106-R04849005-1.pdf: 9777450 bytes, checksum: 313b6d6dcda2db4fc3f688a70bc88c9a (MD5) Previous issue date: 2017 | en |
dc.description.tableofcontents | 致謝 (Acknowledgement)………………………………………....………………....i
中文摘要 (Chinese Abstract)… …………………………………………...……...iii Abstract…………………………………………....………………………………......…vii Chapter 1 Introduction………………………………………....…………………..1 Chapter 2 Literature Review………………………...……………………………4 2.1 Global Epidemiology of Dengue..…………………………….…………4 2.2 Clinical Spectrum of Dengue.……..…………………………………..…6 2.3 Basic Knowledge of Dengue Virus and Advanced Concepts in Pathogenesis of Severe Dengue………………………………….…………..9 2.3.1 Introduction of Dengue Virus……...………………………………….9 2.3.2 Risk Factors Associated with Severe Dengue……………….10 2.3.3 Evolution of Concepts in Pathogenesis of Severe Dengue..........................................................................................11 2.3.4 The Role of NS1 in Dengue Viral Pathogenesis……….…….14 Chapter 3 Objectives, Specific Aims and Hypotheses……..………18 3.1 Objectives………………………………………....…………………...……….18 3.2 Specific Aims……………………………………..…………………………...18 3.3 Hypothesis……………………………………………...……………………...19 Chapter 4 Materials and Methods…………….…..…………………………20 4.1 Study design and sample collections…………………………..……20 4.2 Cell culture and Virusculture……………………….…………………….20 4.2.1 Cells used in this study….…………….……………………………20 4.2.2.1 Virus strains used in this stud….………..………………………21 4.2.2.2 Plaque purification………...........…………………………….…...22 4.3 Virus sequencing…………………………………….…………..……………23 4.3.1 RNA extraction, two-step RT-PCR…………………….…….……23 4.3.2 Sanger sequencing and sequence analyses.……….…….24 4.4 Quantification of viral titer………………………………….………….….24 4.4.1 Focus-forming assay……………………………………….....…….24 4.4.2 Quantitative PCR (qPCR) ……………………………………….………25 4.5 Quantification of non-structural protein 1 (NS1)………..........26 4.5.1 Enzyme-Linked ImmunoSorbent Assay (ELISA) ………..26 4.5.2 SDS-polyacrylamide gel electrophoresis (SDS-PAGE).27 4.5.3 Western blot………………………………………………………….....28 4.6 Attachment assay…………………..…………….………………………….29 4.7 Penetration assay…………………………….……………….….………….29 4.8 Replication assay……………………………………..………......….…….30 4.9 NS1 purification by immunoaffinity chromatography….…....31 4.10 Immunofluorescence assay…………………….………………….…….32 4.11 Statistical analyses and graphics……....……………….………..…32 Chapter 5 Results……………………………………………………….…………..34 5.1 Basics characteristics and clinical symptoms of the patients in these two DENV-2 caused epidemics….……………….…….…..…….34 5.2 Genotypic comparison of the two representative DENV-2 strains isolated from the two epidemics (the 2002 Kaohsiung and the 2015 Tainan)…........................................................................36 5.3 Phenotypic comparison of two DENV-2 plaque-purified representative strains (2002-KH-A3L and 2015-TN-6B1) in different cells………….…….…….…….…….…….…….…….…….…….……....38 5.3.1 Comparison in DENV-2 viral plaque morphologies in BHK cells and growth kinetics in Vero and C6/36 cells..………….….…...38 5.3.2 Differences in cell binding, penetration and replication efficiency…….….…….…….…….…….…….…….…….…….…….…….……......40 5.3.3 Differences in the expression levels of intracellular, extracellular and total viral NS1 in Vero Cells………………..…….…...40 5.4 Differences of the two tested Taiwan DENV-2 strains in their viral infectivity and replication in human intestinal Caco-2 cells.41 Chapter 6 Discussion…………………….…….....................................43 6.1 Integration of clinical, epidemiological and virological characteristics….….…….…….…….…….…….…….…….…….…….…….…...43 6.2 The role of NS1…………………………….…………………………….….…44 6.3 Limitations of the study……………………………………………….…...46 6.4 Recommendations…………………………………………….....………….48 6.5 Future Directions…………………………………………………….………..49 References……………………………………………………………...………………..51 Figures……………………………………………………………………….....…………60 Tables………………………………………………………………………....….………..85 Appendix……………………………………………………………………....….………93 | |
dc.language.iso | en | |
dc.title | 比較南台灣2002年與2015年流行的第二型都會基因型登革病毒基因與表現型及流行病學特徵 | zh_TW |
dc.title | Genetic, Phenotypic and Epidemiological Characteristics of the Two Cosmopolitan Genotype Dengue Serotype 2 Viruses Causing Epidemics in 2002 and 2015 in Southern Taiwan | en |
dc.type | Thesis | |
dc.date.schoolyear | 105-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 顧家綺(Chia-Chi Ku),伍安怡(Betty Wu-Hsieh),張淑媛(Sui-Yuan Chang),高全良(Chuan-Liang Kao),余佳慧(Linda Chia-Hui Yu) | |
dc.subject.keyword | 登革熱,台灣,台南,高雄,腸胃道症狀,2002年,2015年, | zh_TW |
dc.subject.keyword | Dengue fever,Taiwan,Tainan,Kaohsiung,Gastrointestinal symptoms,2002,2015, | en |
dc.relation.page | 106 | |
dc.identifier.doi | 10.6342/NTU201702283 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2017-08-01 | |
dc.contributor.author-college | 公共衛生學院 | zh_TW |
dc.contributor.author-dept | 流行病學與預防醫學研究所 | zh_TW |
顯示於系所單位: | 流行病學與預防醫學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-106-1.pdf 目前未授權公開取用 | 9.55 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。